Pinnacle Biologics has entered into an agreement with Pharmexx to expand sales support activities in a number of countries in Western Europe. Terms of the agreement were not disclosed.
Subscribe to our email newsletter
Viren Grover, vice-chairman of Pinnacle Biologics, said: “We are pleased to conclude this agreement with Pharmexx, which allows us a cost effective way to support our sales and marketing activities for Ethyol in key European markets where we believe there is upside potential.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.